Sarah Boseley asks if the latest guidelines on drugs for MS sufferers are good news or bad [science |2015-12-22]
Embed Code (recommended way)
Embed Code (Iframe alternative)
Please login or signup to use this feature.

With Nice announcing its latest guidelines on drugs and clinical care, the Guardian's health editor is joined by an expert panel to discuss the implications for those who suffer from MS Dec 04, 2015

Licence : All Rights Reserved